Fundraising Fox

Annie Mitsak

Investor

Partner at Cure Ventures Β· Principal at Omega Funds

Boston, Massachusetts, United States

FoundedAlessa Therapeutics

About

Partner with over ten years in academic licensing and venture investing. Previously spent over six years on the Omega Funds investment team and worked at MIT's Technology Licensing Office.

Experience

  1. Triton Therapeutics, Inc.Board Membercurrent2025 β€” present
  2. Alessa Therapeutics, Inc.Board Membercurrent2025 β€” present
  3. Cure VenturesPartnercurrent2023 β€” presentBoston, Massachusetts, United States
  4. Photys TherapeuticsBoard Observer2021 β€” 2022
  5. Rectify PharmaBoard Observer2021 β€” 2022
  6. Scorpion TherapeuticsBoard Observer2021 β€” 2022
  7. Anjarium BiosciencesBoard Observer2021 β€” 2022
  8. Omega FundsPrincipal2019 β€” 2022
  9. Omega FundsAssociate2015 β€” 2019Boston, MA
  10. Ikena OncologyBoard Observer2020 β€” 2021
  11. Checkmate PharmaceuticalsBoard Observer2020
  12. Trevi Therapeutics, Inc.Member Board Of Directors2018 β€” 2020
  13. Massachusetts Institute of Technology (MIT)Associate Technology Licensing Officer2014 β€” 2015
  14. Massachusetts Institute of Technology (MIT)Technology Licensing Associate2012 β€” 2014Cambridge, MA
  15. Nelsen BiomedicalIndependent Consultant2015
  16. University of MichiganPostdoctoral fellow2012Ann Arbor, MI
  17. Kaplan Test Prep and AdmissionsGRE Instructor2007
  18. Penn State UniversityResearch Assistant2005
  19. Johns Hopkins UniversityResearch Assistant2004Baltimore, MD

Education

  1. University of MichiganPhD, Biomedical Engineering2006 β€” 2012
  2. University of MichiganM.S., Biomedical Engineering2006 β€” 2007
  3. University of VirginiaBS, Biomedical Engineering2002 β€” 2006

Skills & more

Contract NegotiationDrafting AgreementsPeer MentoringPatent Portfolio AnalysisBiomedical EngineeringLicensing

From Annie's professional profile.

Same school

Shared employers

Investments

Per SEC Form D filings.

Colleagues at Cure Ventures

Network6

Investors connected to Annie in public investor directories β€” a warm-intro map.